Literature DB >> 2480899

Phenotypic discrimination between thymic and extrathymic CD4-CD8- and CD4+CD8+ porcine T lymphocytes.

A Saalmüller1, W Hirt, M J Reddehase.   

Abstract

The composition of the T lymphocyte population in swine is special in that in addition to the CD4-CD8+ subpopulations, CD4-CD8- and CD4+CD8- and CD4+CD8+ subpopulations are prominent in the peripheral circulating as well as in the resident T lymphocyte pools. Since the same phenotypes are characteristic of thymic populations, it was asked whether the unusual distribution in swine may result from an emigration of thymic precursor phenotypes to the periphery. This explanation was refuted, as all thymic subpopulations were found to express CD1, albeit with differences in antigen density, whereas all extrathymic subpopulations lack CD1. The cellular distribution of CD2 in swine is without precedent among all species studied. Whereas in sheep and cattle the extrathymic CD4-CD8- subpopulation is known to entirely lack CD2 and to have a low propensity for homing to lymphoid tissues, the CD4-CD8- subpopulation in swine splits into CD2+ and CD2- subsets, both of which do reside in lymphoid tissues. While CD2+CD4-CD8- T lymphocytes are rare in the circulating pool, this subset accumulates in spleen and lymph nodes. This may indicate a role for CD2 in homing. Thus the species swine is immunologically unique, not only because of having CD1-CD2+CD4+CD8+ T lymphocytes in the periphery, but also with regard to subdivision and homing behavior of its CD4-CD8- T lymphocyte subpopulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480899     DOI: 10.1002/eji.1830191107

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Poxvirus-induced immunostimulating effects on porcine leukocytes.

Authors:  V Fachinger; T Schlapp; W Strube; N Schmeer; A Saalmüller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Differentiation between MHC-restricted and non-MHC-restricted porcine cytolytic T lymphocytes.

Authors:  T Pauly; E Weiland; W Hirt; C Dreyer-Bux; S Maurer; A Summerfield; A Saalmüller
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

Review 3.  The isolator piglet: a model for studying the development of adaptive immunity.

Authors:  J E Butler; Marek Sinkora
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Pathogenesis of classical swine fever: B-lymphocyte deficiency caused by hog cholera virus.

Authors:  M Susa; M König; A Saalmüller; M J Reddehase; H J Thiel
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Discrimination between two subsets of porcine CD8+ cytolytic T lymphocytes by the expression of CD5 antigen.

Authors:  A Saalmüller; W Hirt; S Maurer; E Weiland
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  Crystallization and preliminary X-ray crystallographic studies of swine CD8α.

Authors:  Nianzhi Zhang; Jianxun Qi; Xiaocheng Pan; ZhaoSan Chen; Xin Li; Feng Gao; Chun Xia
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-07-19

7.  Adaptive Immune Responses following Senecavirus A Infection in Pigs.

Authors:  Mayara F Maggioli; Steve Lawson; Marcelo de Lima; Lok R Joshi; Tatiane C Faccin; Fernando V Bauermann; Diego G Diel
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

8.  Functional and phenotypic analysis of porcine peripheral blood CD4/CD8 double-positive T cells.

Authors:  F A Zuckermann; R J Husmann
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

9.  Distribution of porcine CD4/CD8 double-positive T lymphocytes in mucosa-associated lymphoid tissues.

Authors:  F A Zuckermann; H R Gaskins
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

10.  Differential expression of CD8 epitopes amongst porcine CD8-positive functional lymphocyte subsets.

Authors:  H Yang; R M Parkhouse
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.